| NCT ID | NCT05788432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación EPIC |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,028 participants |
| Start Date | 2023-03-28 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,028 participants in total. It began in 2023-03-28 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.
Eligibility Criteria
Inclusion Criteria: * Patients treated with Sequent please neo according to routine hospital practice and following instruction for use. * Informed Consent Signed. Exclusion Criteria: * Patient life expectancy less than 12 months. * Contraindication for antiplatelet therapy. * Not meet inclusion criteria.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05788432 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05788432 currently recruiting?
Yes, NCT05788432 is actively recruiting participants. Contact the research team at oriolrodriguez@gmail.com for enrollment information.
Where is the NCT05788432 trial being conducted?
This trial is being conducted at Alava, Spain, Alicante, Spain, Badajoz, Spain, Badalona, Spain and 11 additional locations.
Who is sponsoring the NCT05788432 clinical trial?
NCT05788432 is sponsored by Fundación EPIC. The trial plans to enroll 2,028 participants.